Month: August 2021

A drug meant to treat cholesterol was found to reduce coronavirus infection by 70% in lab studies, with researchers calling for additional clinical trials among hospitalized COVID-19 patients. A team of researchers from the U.K. and Italy published findings in the Frontiers in Pharmacology journal Friday, finding that fenofibrate and fenofibric acid resulted in a significant reduction in coronavirus infection in human cells when the drug was used in safe and approved concentrations, according to a news release posted Friday. CLICK HERE TO FIND A COVID-19 VACCINE NEAR YOU "Our data indicates that fenofibrate may have the potential to reduce the severity of COVID-19 symptoms and also virus spread," Dr. Elisa Vicenzi of the San Raffaele Scientific Institute in Milan and co-author, said i...

Public health experts warn that ‘vaccines do not eliminate all risk’ amid early signs jabs may not stop Delta transmission. Hundreds of fully vaccinated people in England have been hospitalised with the highly contagious Delta coronavirus variant, scientists said on Friday. In its latest COVID-19 update, Public Health England (PHE) also warned there were early signs that people who have been inoculated may be able to transmit the Delta strain as easily as those who have not received any jabs. From July 19 to August 2, 55.1 percent of the 1,467 people hospitalised with the Delta variant were unvaccinated, PHE said, while 34.9 percent – or 512 people – had received two doses. Dubbed “freedom day”, July 19 was the date England significantly eased lockdown restrictions. All vaccin...

MOUNTAIN VIEW (KPIX) — As the Delta variant of the coronavirus fuels an ongoing COVID wave, Bay Area health experts are keeping a close eye on yet another variant: Delta Plus. “We believe that it’s at least as bad as Delta,” said Dr. Peter Chin-Hong, an infectious disease specialist at the University of California San Francisco. READ MORE: California Mandates COVID Vaccinations for All Health Care Workers “We don’t know if it’s even worse than Delta yet. When I say worse we think about number one: is it more transmissible? Number two, does it evade vaccines? And, number three, does it make you sicker?” The Santa Clara County Public Health Department has detected 46 cases of the Delta Plus mutation, according to their latest statistics. It is not the dominant strain in the area,...

Johnson & Johnson's coronavirus vaccine is effective at preventing severe disease among those infected with the delta variant, according to a large-scale trial in South Africa.  The trial, which involved nearly 480,000 health care workers in the country, is the first instance of significant evidence that the J&J shot works against the highly contagious variant, trial co-lead Glenda Gray said.  The vaccine proved to be 71 percent effective against hospitalization and up to 96 percent effective against death, Gray said.  The news from South Africa's trial comes after a study in July found that the J&J vaccine may be less effective in batting coronavirus variants than the Pfizer or Moderna vaccines. The results found Pfizer and Moderna's shots to be 94-95 percent effectiv...

Johnson & Johnson's coronavirus vaccine is effective at preventing severe disease among those infected with the delta variant, according to a large-scale trial in South Africa.  The trial, which involved nearly 480,000 health care workers in the country, is the first instance of significant evidence that the J&J shot works against the highly contagious variant, trial co-lead Glenda Gray said.  The vaccine proved to be 71 percent effective against hospitalization and up to 96 percent effective against death, Gray said.  The news from South Africa's trial comes after a study in July found that the J&J vaccine may be less effective in batting coronavirus variants than the Pfizer or Moderna vaccines. The results found Pfizer and Moderna's shots to be 94-95 percent effectiv...

Johnson & Johnson's coronavirus vaccine is effective at preventing severe disease among those infected with the delta variant, according to a large-scale trial in South Africa.  The trial, which involved nearly 480,000 health care workers in the country, is the first instance of significant evidence that the J&J shot works against the highly contagious variant, trial co-lead Glenda Gray said.  The vaccine proved to be 71 percent effective against hospitalization and up to 96 percent effective against death, Gray said.  The news from South Africa's trial comes after a study in July found that the J&J vaccine may be less effective in batting coronavirus variants than the Pfizer or Moderna vaccines. The results found Pfizer and Moderna's shots to be 94-95 percent effectiv...

Johnson & Johnson's coronavirus vaccine is effective at preventing severe disease among those infected with the delta variant, according to a large-scale trial in South Africa.  The trial, which involved nearly 480,000 health care workers in the country, is the first instance of significant evidence that the J&J shot works against the highly contagious variant, trial co-lead Glenda Gray said.  The vaccine proved to be 71 percent effective against hospitalization and up to 96 percent effective against death, Gray said.  The news from South Africa's trial comes after a study in July found that the J&J vaccine may be less effective in batting coronavirus variants than the Pfizer or Moderna vaccines. The results found Pfizer and Moderna's shots to be 94-95 percent effectiv...

Johnson & Johnson's coronavirus vaccine is effective at preventing severe disease among those infected with the delta variant, according to a large-scale trial in South Africa.  The trial, which involved nearly 480,000 health care workers in the country, is the first instance of significant evidence that the J&J shot works against the highly contagious variant, trial co-lead Glenda Gray said.  The vaccine proved to be 71 percent effective against hospitalization and up to 96 percent effective against death, Gray said.  The news from South Africa's trial comes after a study in July found that the J&J vaccine may be less effective in batting coronavirus variants than the Pfizer or Moderna vaccines. The results found Pfizer and Moderna's shots to be 94-95 percent effectiv...